An estimated 27% of U.S. adults with diabetes are using glucagon-like peptide-1 receptor agonists (GLP-1 RAs) - a type of ...
Patients in American hospitals and long-term care facilities face a growing threat from Candida auris, a drug-resistant ...
A study on over 800k adults with type 2 diabetes found that semaglutide and other GLP-1 drugs did not increase or decrease ...
The Supreme Court has mandated that all States and Union Territories develop a comprehensive policy within three months for ...
The breadth of the proposal suggests that many organizations will need to reassess existing policies, contractual ...